← Leaderboards
Nabil J. Alkayed
Johns Hopkins University
$25,658,018
Attributed
$26,333,159
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,333,159 · 15
By mechanism
RF1$9,686,188 · 3
R01$8,934,074 · 3
T32$2,476,746 · 2
R42$1,350,283 · 1
P01$1,220,598 · 1
U01$994,455 · 1
Top collaborators
- Halina Offner2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Daniel M Raben$3,688,739
- Nancy E Davidson$32,860,580
- Mackenzie Kui$88,995
- Arlene A Forastiere$3,988,680
- Ariel Yosef Isser$74,712
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainStrokeEpoxide HydrolaseSignal TransductionIn VivoMediatingLinkPreventEicosanoidsInjuryInfarctionEnzymesTissuesReceptorIschemiaMiddle Cerebral Artery OcclusionEndotheliumBlood VesselsCerebral IschemiaCellsInnovationLipidsPlayCerebrovascular
Grant awards (52)
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)$1,309,221
RF1 · FY2025 · AG · contact PI
Training in Translational Science and Cardiovascular Research$339,796
T32 · FY2025 · HL · contact PI
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke$311,850
U01 · FY2025 · NS · contact PI
Training in Translational Science and Cardiovascular Research$566,018
T32 · FY2024 · HL · contact PI
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke$336,105
U01 · FY2024 · NS · contact PI
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia$2,244,471
RF1 · FY2023 · AG · contact PI
Neuroinflammatory Mechanisms of Vascular Cognitive Impairment$1,659,018
RF1 · FY2023 · AG · contact PI
Pericyte phenotypic switching in diabetic post-stroke cognitive impairment (PSCI)$696,183
R56 · FY2023 · NS · contact PI
Training in Translational Science and Cardiovascular Research$529,763
T32 · FY2023 · HL · contact PI
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke$346,500
U01 · FY2023 · NS · contact PI
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)$1,978,218
RF1 · FY2022 · AG · contact PI
Endothelial-Pericyte Crosstalk in Diabetic Stroke$417,539
R01 · FY2022 · NS · contact PI
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)$251,946
R41 · FY2022 · NS · contact PI
Endothelial-Pericyte Crosstalk in Diabetic Stroke$417,539
R01 · FY2021 · NS · contact PI
Endothelial-Pericyte Crosstalk in Diabetic Stroke$204,820
R01 · FY2021 · NS · contact PI
Endothelial-Pericyte Crosstalk in Diabetic Stroke$417,539
R01 · FY2020 · NS · contact PI
Endothelial-Pericyte Crosstalk in Diabetic Stroke$417,539
R01 · FY2019 · NS · contact PI
Endothelial-Pericyte Crosstalk in Diabetic Stroke$447,949
R01 · FY2018 · NS · contact PI
Training in Translational Science and Cardiovascular Medicine$152,566
T32 · FY2018 · HL · contact PI
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)$2,495,260
RF1 · FY2017 · AG · contact PI
Training in Translational Science and Cardiovascular Medicine$438,522
T32 · FY2017 · HL · contact PI
DRα1-MOG: A Novel Immunomodulatory Therapeutic for Stroke$299,186
R41 · FY2017 · NS · contact PI
Training in Translational Science and Cardiovascular Medicine$18,584
T32 · FY2017 · HL · contact PI
Training in Translational Science and Cardiovascular Medicine$431,497
T32 · FY2016 · HL · contact PI
Peroxisomal Biogenesis after Cerebral Ischemia$354,855
R01 · FY2015 · NS · contact PI
Mechanism of Vascular Dysfunction after Stroke in Postmenopausal Female$336,875
R01 · FY2015 · NS · contact PI
Peroxisomal Biogenesis after Cerebral Ischemia$353,844
R01 · FY2014 · NS · contact PI
Mechanism of Vascular Dysfunction after Stroke in Postmenopausal Female$333,507
R01 · FY2014 · NS · contact PI
Endothelial Mechanism of Vascular Cognitive Impariment (VCI)$192,500
R21 · FY2014 · AG · contact PI
A Novel Intervention Strategy for Stroke with RTL Therapy$668,668
R42 · FY2013 · NS
Peroxisomal Biogenesis after Cerebral Ischemia$347,433
R01 · FY2013 · NS · contact PI
Mechanism of Vascular Dysfunction after Stroke in Postmenopausal Female$325,085
R01 · FY2013 · NS · contact PI
Endothelial Mechanism of Vascular Cognitive Impariment (VCI)$231,000
R21 · FY2013 · AG · contact PI
A Novel Intervention Strategy for Stroke with RTL Therapy$681,615
R42 · FY2012 · NS
Peroxisomal Biogenesis after Cerebral Ischemia$409,664
R01 · FY2012 · NS · contact PI
Mechanism of Vascular Dysfunction after Stroke in Postmenopausal Female$336,875
R01 · FY2012 · NS · contact PI
Peroxisomal Biogenesis after Cerebral Ischemia$387,743
R01 · FY2011 · NS · contact PI
Mechanism of Vascular Dysfunction after Stroke in Postmenopausal Female$336,875
R01 · FY2011 · NS · contact PI
Soluble Epoxide Hydrolase as a Novel Therapeutic Target of Stroke$333,087
R01 · FY2010 · NS · contact PI
Soluble Epoxide Hydrolase as a Novel Therapeutic Target of Stroke$336,452
R01 · FY2009 · NS · contact PI
Role of CART in Estrogen-Mediated Neuroprotection$244,766
P01 · FY2009 · NS · contact PI
Soluble Epoxide Hydrolase as a Novel Therapeutic Target of Stroke$336,452
R01 · FY2008 · NS · contact PI
Role of CART in Estrogen-Mediated Neuroprotection$244,766
P01 · FY2008 · NS · contact PI
Soluble Epoxide Hydrolase as a Novel Therapeutic Target of Stroke$336,270
R01 · FY2007 · NS · contact PI
Role of CART in Estrogen-Mediated Neuroprotection$252,100
P01 · FY2007 · NS · contact PI
Soluble Epoxide Hydrolase as a Novel Therapeutic Target of Stroke$345,001
R01 · FY2006 · NS · contact PI
Role of CART in Estrogen-Mediated Neuroprotection$239,483
P01 · FY2006 · NS · contact PI
TIA-Induced Ischemic Tolerance via P450 Epoxygenase$350,550
R01 · FY2005 · NS
Role of CART in Estrogen-Mediated Neuroprotection$239,483
P01 · FY2005 · NS
TIA-Induced Ischemic Tolerance via P450 Epoxygenase$350,550
R01 · FY2004 · NS
TIA-Induced Ischemic Tolerance via P450 Epoxygenase$350,550
R01 · FY2003 · NS
TIA-Induced Ischemic Tolerance via P450 Epoxygenase$349,481
R01 · FY2002 · NS